Pediatric Respiratory Disease: Emerging Insights for the Pediatric Practice

Sponsorship Statement: This continuing medical education activity is jointly sponsored by Infectious Diseases in Children® and Vindico Medical Education.

Support Statement: This activity is supported by an educational grant from MedImmune.

Learning Objectives:
Upon successful completion of this activity, participants should be able to:

• Discuss the burden of respiratory syncytial virus (RSV) disease and prevalence of RSV infection.
• Interpret the 2009 modified American Academy of Pediatrics (AAP) recommendations regarding the use of immunoprophylaxis for prevention of RSV infections.
• Evaluate current and emerging RSV management strategies and their impact on established AAP guidelines.

Course Chair:
Michael L. Forbes, MD, FAAP
Pediatric and Adolescent Intensivist
Director, Clinical Research and Outcomes Analysis
Pediatric Critical Care Medicine
Akron Children's Hospital
Akron, Ohio

Title: Applying the American Academy of Pediatrics Modified Guidelines on RSV Immunoprophylaxis

Faculty:
Paul A. Checchia, MD, FAAP, FCCM, FACC
Medical Director, Pediatric Cardiac Intensive Care Unit
St. Louis Children's Hospital
Washington University
St. Louis, Missouri

Title: Current and Emerging Therapeutics and Immunoprophylaxis for RSV

Gary Goodman, MD
Medical Director, Pediatric Intensive Care Unit and Hospitalist Service
CHOC at Mission
Mission Viejo, California

Title: RSV: The Burden of Disease and Seasonal Variability

Continuing Medical Education Information:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Vindico Medical Education and Infectious Diseases in Children®. Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Vindico Medical Education designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, March 1, 2011 to March 31, 2012.

How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the Pretest questions, read the articles, complete the CME Posttest, and complete and complete and submit the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the Posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the Posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)^TM certificate within 4 to 6 weeks.

Planning Committee and Faculty:
Michael L. Forbes, MD, FAAP
Paul A. Checchia, MD, FAAP, FCCM, FACC
Gary Goodman, MD

External Reviewer:
Gary S. Marshall, MD

Medical Writer:
Valerie Zimmerman, PhD

Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears on this page.

The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.

Planning Committee and Faculty members report the following relationship(s):
Michael L. Forbes, MD, FAAP
Consulting Fees: MedImmune

Paul A. Checchia, MD, FAAP, FCCM, FACC
Consulting Fees: MedImmune

Gary Goodman, MD
Consulting Fees: MedImmune
Fees for Non-CME Services Received Directly from Commercial Interest or their Agents: MedImmune

External Reviewer reports the following relationship(s):
Gary S. Marshall, MD
Consulting Fees: GlaxoSmithKline, Merck, Novartis, Sanofi Pasteur
Contracted Research: GlaxoSmithKline, Merck, Novartis, Sanofi Pasteur

Medical Writer reports the following relationship(s):
Valerie Zimmerman, PhD
No relevant financial relationships to disclose

Vindico Medical Education and Infectious Diseases in Children® staff report the following relationship(s):
No relevant financial relationships to disclose

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Overview:
Respiratory syncytial virus (RSV) represents a significant disease burden in infants and young children. This monograph will review the prevalence of RSV, the seasonal and regional variability of the virus, the American Academy of Pediatrics latest guidelines for RSV immunoprophylaxis, and current and emerging immunoprophylactic measures and therapeutics.

Target Audience:
The intended audience for this activity is pediatricians, pediatric nurse practitioners, and other health care professionals involved in the treatment of infants and children.

Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.

Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright© 2011 Slack Incorporated®. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education and Infectious Diseases in Children® continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education and Infectious Diseases in Children®. Neither Vindico Medical Education, Infectious Diseases in Children®, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.